cobalt has been researched along with geldanamycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, CY; Friedlander, DR; Gagner, JP; Newcomb, EW; Nomura, M; Nomura, N; Zagzag, D | 1 |
| Koga, F; Neckers, LM; Tsutsumi, S | 1 |
2 other study(ies) available for cobalt and geldanamycin
| Article | Year |
|---|---|
Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion.
Topics: Antibiotics, Antineoplastic; Benzoquinones; Cell Movement; Cobalt; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactams, Macrocyclic; Neoplasm Invasiveness; Osmolar Concentration; Phosphoric Monoester Hydrolases; Phosphorylation; Protein-Tyrosine Kinases; PTEN Phosphohydrolase; Quinones; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.
Topics: Antibiotics, Antineoplastic; Benzoquinones; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Extracellular Matrix Proteins; Feedback, Physiological; Female; Fibronectins; Focal Adhesions; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; HSP90 Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Integrin beta3; Lactams, Macrocyclic; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Proto-Oncogene Proteins c-met; Stress Fibers; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A | 2007 |